Literature DB >> 8891136

Inhibition of murine leukemia virus with poly-2'-O-(2,4-dinitrophenyl)poly[A].

M A Ashun1, Y Hu, I Kang, C C Li, J H Wang.   

Abstract

Poly-2'-O-(2,4-dinitrophenyl)poly[A] (DNP-poly[A] is a potent inhibitor of reverse transcriptases from a variety of sources (I. Kang and J. H. Wang, J. Biol. Chem. 269:12024-12031, 1994). In the present study, its inhibitory effect on the reverse transcriptase (RT) from Moloney murine leukemia virus (MuLV) was investigated. DNP-poly[A] was found to enter the virus spontaneously and to completely inhibit the RT within 30 min at 0 degree C. The inhibitor was also spontaneously transported into isolated human lymphocytes and leukocytes at 37 degrees C. Animal studies have demonstrated the effectiveness of DNP-poly[A] as an antiviral drug when administered intraperitoneally at various doses from 1 to 100 mg/kg of body weight. MuLV-infected mice show the presence of RT in their blood as well as increased numbers of leukocytes. After the administration of DNP-poly[A] at a dosage of 100 mg/kg of body weight three times a week over a 3-week period, RT could no longer be detected by an ultrasensitive RT-PCR assay. Autopsy showed that the spleens of infected but untreated mice were enlarged 2- to 10-fold, with fused nodules and the proliferation of large abnormal lymphocytes, whereas the spleens of infected but treated mice resembled the normal spleens of uninfected control mice. These observations indicate that further study of DNP-poly[A] as a general antiretroviral agent is desirable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891136      PMCID: PMC163526     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations.

Authors:  J B MOLONEY
Journal:  J Natl Cancer Inst       Date:  1960-04       Impact factor: 13.506

2.  3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase.

Authors:  M H St Clair; C A Richards; T Spector; K J Weinhold; W H Miller; A J Langlois; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

3.  Selective removal of ribonucleases from solution with covalently anchored macromolecular inhibitor.

Authors:  M H Rahman; I Kang; R G Waterbury; U Narang; F V Bright; J H Wang
Journal:  Anal Chem       Date:  1996-01-01       Impact factor: 6.986

4.  Purification and assay of murine leukemia viruses.

Authors:  C J Sherr; G J Todaro
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

5.  Selective action of 3'-azido-3'-deoxythymidine 5'-triphosphate on viral reverse transcriptases and human DNA polymerases.

Authors:  P Huang; D Farquhar; W Plunkett
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

6.  Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement.

Authors:  H Pyra; J Böni; J Schüpbach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

8.  Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Stromberg; N E Hurley; N L Davis; R R Rueckert; E Fleissner
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

9.  Design of structure-based reverse transcriptase inhibitors.

Authors:  I Kang; J H Wang
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

10.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Authors:  P A Furman; J A Fyfe; M H St Clair; K Weinhold; J L Rideout; G A Freeman; S N Lehrman; D P Bolognesi; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  1 in total

1.  An integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonuclease.

Authors:  Dimitrios Vlachakis; Athanasia Pavlopoulou; Georgia Tsiliki; Dimitri Komiotis; Constantinos Stathopoulos; Nikolaos A A Balatsos; Sophia Kossida
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.